MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$40,000K
Proceeds from sale of
property and equipment
$241K
Net cash provided by
(used in) investing...
$25,528K
Canceled cashflow
$14,713K
Net decrease in
cash, cash...
-$27,154K
Canceled cashflow
$25,528K
Accrued expenses and
other current...
$6,658K
Stock-based compensation
expense
$1,977K
Losses on property and
equipment, net
-$1,911K
Depreciation and
amortization expense
$1,404K
Prepaid expenses and
other current assets
-$1,182K
Operating lease
right-of-use assets
-$986K
Other noncurrent
assets
-$67K
Purchases of marketable
securities
$14,713K
Net cash used in
operating activities
-$52,680K
Canceled cashflow
$14,185K
Net cash used in
financing activities
-$2K
something is missing
$35,725K
Other income and
interest income, net
$4,985K
Operating lease
liabilities
-$33,793K
Loss on lease
termination
$25,490K
Net loss
-$5,520K
Deferred revenue
-$1,202K
Accretion of discount on
marketable securities, net
$696K
Accounts payable
-$168K
Tax withholding
payments related to net...
$2K
Canceled cashflow
$40,710K
Collaboration revenue
$11,082K
Loss from operations
-$46,230K
Canceled cashflow
$11,082K
Loss on lease
termination
$23,838K
Total operating
expenses
$57,312K
Canceled cashflow
$23,838K
Personnel-related
$30,342K
Facilities-related
$16,392K
Preclinical and
manufacturing
$12,910K
Consulting and
professional services
$9,872K
Stock-based compensation
$5,681K
Other
$3,151K
Lab supplies
$2,802K
Back
Back
Cash Flow
source: myfinsight.com
Generation Bio Co. (GBIO)
Generation Bio Co. (GBIO)